Global Brain Monitoring Market to Experience Exponential Revenue Growth in Next FIVE Years

The study involved four major activities in estimating the current size of the Brain Monitoring Research Market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

Market Size Estimation:

The global brain monitoring market size is estimated to be USD 8.6 billion by 2025 from USD 6.3 billion in 2020, at a CAGR of 6.2%.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=909 

Major Growth Boosting Factors:

The brain monitoring market is mainly driven by factors such as the increasing incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, growth in the number of traumatic brain injuries, and increasing applications of brain monitoring in clinical trials. 

The rising demand for non-invasive and minimally invasive devices, the expanding therapeutic applications of brain monitoring devices, and the growing healthcare market in emerging economies are also expected to provide opportunities for growth for players in the market.

By end user type, the hospital segment accounted for the largest share of the brain monitoring market in 2019.

Based on end-users, the global Brain Monitoring Research Market is segmented into hospitals, neurology centers, diagnostic centers, ASCs & clinics, and other end users. The hospital segment held the largest share of the global brain monitoring market in 2019. Brain monitoring is a complex process, requiring expensive and advanced devices and equipment that are mainly found in hospitals.

Hospitals also see a considerably larger inflow of patients as compared to small clinics and other end users. Additionally, brain monitoring devices pose a considerable burden in terms of maintenance expenses on healthcare facilities; hospitals, more than other end-users, can bear such costs. Hence, brain monitoring devices are mostly used in hospitals, which consequently account for the largest share of this market segment.

North America accounted for the largest share of the global brain monitoring market in 2019.

The brain monitoring market, by region, is segmented into North America, Europe, APAC, and the RoW. North America accounted for the largest share of the brain monitoring market in 2018. This can be attributed to the growing incidence of neurological diseases, a growing number of clinical trials of brain monitoring products, and the availability of medical reimbursement in the US.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=909

Some of the leading players in the Brain Monitoring Research Market include Natus Medical, Inc. (US), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), Compumedics, Ltd. (Australia), Medtronic (Ireland), CAS Medical Systems, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Advanced Brain Monitoring (US), Masimo Corporation (US), Spiegelberg GmbH & Co. KG (Germany), Cadwell Industries (US), NeuroWave Systems, Inc. (US), Nonin Medical, Inc. (US), Integra LifeSciences Corporation (US), Neurosoft (Russia), and Rimed (US).

Surgical Imaging Market - Global Industry Segmentation | Future Forecasts

The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.|

The key factors driving the growth of Surgical Imaging Applications Market are growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and increasing demand for minimally invasive procedures. The growing demand for data integrated imaging systems and high growth in emerging markets like Asia Pacific is an opportunity for the market to grow.

The overall surgical imaging market is expected to grow from USD 1.25 billion by 2017 to USD 1.63 billion in 2022, at a CAGR of 5.5% from 2017 to 2022.

Target Audience:

# C-arms manufacturers and distributors.
# Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies).
# Medical device vendors/service providers.
# Research institutes.
# Niche companies manufacturing imaging systems.
# Research and consulting firms.
# Venture capitalists.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

By application, the orthopedic and trauma surgeries segment is expected to command the largest share of the market in 2017

On the basis of application, the market has been segmented into orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications (urology and endobronchial & thoracic surgery). The orthopedic and trauma surgeries segment is expected to command the largest share of the market in 2017. The large share and high growth of this segment can be attributed to factors such as increasing popularity of minimally invasive procedures in orthopedic and trauma surgeries and the advantage of 3D navigation with the use of C-arms.

Critical questions the report answers:

# Where will all these developments take the industry in the mid to long term?
# What are the upcoming industry applications for surgical imaging?

North America to dominate the market in 2017

North America is expected to account for the largest share of the Surgical Imaging Applications Market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.

Major Market Developments:

# In 2017, Koninklijke Philips partnered with Government of Kenya and the United Nations to Establish the SDG (Sustainable Development Goals) Partnership Platform in Kenya to make primary healthcare more accessible.

# In 2017, Koninklijke Philips established its first innovation center in Moscow, Russia.

# In 2017, Siemens Received US FDA approval for its Cios Fusion, Cios Connect, and Cios Select.

# In 2017, Ziehm Imaging Launched the new version of Ziehm Vision FD with a complementary metal oxide semiconductor (CMOS) flat-panel detector and a new CMOS flat-panel detector which allows for display of smaller pixels in the same quality.

# In 2016, Shimadzu Corporation established an indirectly-owned subsidiary—Shimadzu Malaysia Sdn Bhd.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=210534462

Major Industry Leaders:

The surgical imaging market is emerging and fragmented in nature with various regional and international players. In 2016, the surgical imaging market was dominated by a few large players and several small players.

Players in this market compete with each other to deliver superior quality products that are technologically advanced and to provide well-regulated customer service functions. Major companies in this market are GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany).

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017.

The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic. Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

GE Healthcare (US), Koninklijke Philips (Netherlands), Siemens (Germany), and Ziehm Imaging (Germany) are the key players in the Surgical Imaging Applications Market. Other players involved in this market are Hologic (US), Shimadzu Corporation (Japan), OrthoScan (US), Medtronic (US), Toshiba Medical Systems Corporation (Japan), GENORAY (South Korea), Eurocolumbus (Italy), and Allengers Medical Systems (India).

Global Gene Panel Market to Grow at Steady Rate in the Near Future

The growth of this market is mainly driven by factors such as the increasing prevalence of chronic diseases, growing company initiatives, and growing adoption of gene panels owing to their benefits such as cost-efficiency and simplified the workflow.

The global gene panels market is expected to reach USD 2.95 Billion by 2023 from USD 1.22 Billion in 2018, at a CAGR of 19.2%.

Target Audience for this Report:

# NGS equipment manufacturers, vendors, and distributors
# NGS sequencing services companies
# NGS bioinformatics/data analysis companies
# Research institutes and government organizations
# Venture capitalists and government funding organizations
# Research and consulting firms
# Healthcare institutions
# Pharmaceutical and biotechnology companies
# Contract manufacturing organizations
# Contract research organizations

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101282859

The research and academic institutes segment is projected to grow at the highest CAGR during the forecast period.

Based on end user, the market is segmented into research & academic institutes, hospital & diagnostic laboratories, and pharmaceutical & biotechnology companies. The research and academic institutes segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing government funding programs across the globe and the focus of market players on providing efficient gene panels.

The objectives of this study are as follows:

# To define, describe, and forecast the global gene panel market by product & service, technique, design, application, end user, and region.

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players.

# To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World.

# To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments in the gene panel market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities.

North America is expected to dominate the gene panels market in 2018

In 2018, North America is expected to hold the largest share of the gene panels market followed by Europe. The large share of this geographical segment is primarily attributed to the growing research on cancer and inherited rare diseases and the increasing number of NGS-based & clinical applications in the region. Other growth factors include government support for genomics research and the presence of leading NGS providers in this region.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=101282859

Major Leaders:

The gene panels market is fragmented, with the presence of several large as well as emerging players. Prominent players in the gene panels market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US).

Players in this market are adopting various organic and inorganic strategies, such as product launches & upgradations, agreements, partnerships, joint ventures, collaborations, and acquisition to widen their product portfolios and expand their presence in the market. 

European Hemostats & Sealants Market - Emerging Industry Trends & Global Future Forecasts

Main Objectives Behind this Study:

# To define, describe, and forecast the European Hemostats Market (by value) on the basis of focused brand and country.

# To identify micromarkets and the drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the focused brands market.

# To profile focused brands and comprehensively analyze their market shares in focused European countries.

The European hemostats and sealants market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%.

The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Germany commands the largest share of the market

Based on region, the European Hemostats Market is segmented into Germany, the UK, France, Italy, and Spain. Germany dominates the hemostats and sealants market due to its large patient population and the favorable reimbursement scenario for the usage of hemostats.

Key questions addressed in the report:

# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?

# What are the key drivers and restraints in the hemostats and sealants market?

# What are the key brands in the hemostats and sealants market?

# Which are the key countries in the hemostats and sealants market?

# What are the most preferred brands amongst end users?

Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application

Tachosil is expected to dominate the European hemostats and sealants market over the forecast period.

By product, the European hemostats and sealants market (for focused brands) is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil accounts for the largest market share and is anticipated to grow at the highest CAGR during the forecast period. This share can be attributed to high awareness about the brand among end users in European countries.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

The European Hemostats Market is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe.

However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year. Leading players operating in this market are Ethicon (J&J), Baxter, Pfizer, Baxter, C. R. Bard, and B. Braun.

Key Market Players:

Some of the prominent players in the European hemostats and sealants market are B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Global Medical Animation Industry - Major Factors Boosting the Industry Growth

Medical animation is an educational video or movie created using 3D motion graphics to explain the mechanism of action (MoA) of a medical device, biomedical technology, pharmaceutical drug, or an anatomical or biological process.

Animations are used in the medical & pharmaceutical sectors for educational purposes, demonstrations, simulation of surgeries, and analysis and comparative evaluation of treatment among others.

The Medical Animation Application Market is poised to reach USD 301.3 Million by 2021, growing at a CAGR of 20.8% during the forecast period of 2016 to 2021.

The growth of the overall market can be contributed to the rising adoption of medical animation by pharmaceutical and life sciences companies; entry of start-ups; growing pharmaceutical/biopharmaceutical and medical devices industries; increasing penetration of smartphones, tablets, and other mobile platforms; and rising geriatric population coupled with the growing number of surgeries globally.

In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global medical animation market. However, the high cost of medical animation services is expected to restrain the growth of this market to a certain extent.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223188473

Target Audience:

# Medical Animation Service Providers

# Life Sciences Companies

# Medical Device Manufacturers

# Market Research and Consulting Firms

# Healthcare Service Providers

# Teaching Hospitals and Academic Medical Centers (AMCs)

# Medical Research Institutes

# Community Centers

# Regulatory Bodies

# Venture Capitalists

Based on application, the medical animation market is segmented into drug mechanism of action (MoA) and approval, patient education, surgical training and planning, cellular and molecular studies, and other applications (medical simulation, medical legal, forensic reconstruction, and emergency care instructions). The drug mechanism of action (MoA) and approval segment is expected to account for the largest share of the market in 2016; whereas, the patient education segment is projected to grow at the highest CAGR during the forecast period.

Market Growth Restraints:

# High Cost of Medical Animation Services

Opportunities:

# Low Health Literacy

# Emerging Economies

Challenge:

# Dearth of Certified Medical Animators

On the basis of end user, the Medical Animation Application Market is segmented into life science companies; medical device manufacturers; hospitals, surgical centers, and clinics; academic institutes, and other end users (medico-legal firms, forensic departments, government bodies, and insurance companies). The life science companies segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=223188473

On the basis of regions, the medical animation market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased healthcare spending, presence of top market players, increasing number of surgeries in the U.S., and growing medical devices industry in Canada. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

Prominent players in the global Medical Animation Application Market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).

Pharmaceutical Drug Delivery Market - How is the Market Going to Look Like After COVID19

Major Take-Away From This Study:

# Covid Impact on Pharmaceutical Drug Delivery Market, growth/decline in product type/use cases of Pharmaceutical Drug Delivery Market due to cascaded impact of Covid on Extended Ecosystem.

# How top 50 companies in Pharmaceutical Drug Delivery Market are making rapid shifts in their strategies as we speak here.

# Outside-in view of top 50 companies client and client’s clients shifting short-term priorities.

This market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period.

Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for pharmaceutical drugs largely in infectious application.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085

In 2019, the infectious diseases segment accounted for the largest share

Based on application, the pharmaceutical drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.

In 2019, the infectious diseases segment accounted for the largest share of the pharmaceutical drug delivery market. The large share of this segment can be majorly attributed to the increasing prevalence of infectious diseases and increasing company initiatives to enhance R&D related to infectious diseases. Further, spread of COVID-19 has further propelled the market for this application.

Recent Developments in Global Industry:

# In 2020, Johnson & Johnson, Inc collaborated with Biomedical Advanced Research and Development Authority (BARDA), to expedite development and strengthen access through production of coronavirus vaccine.

# In 2020, Johnson & Johnson, Inc collaborated with MeiraGTx Holdings Plc (US) to develop, manufacture and commercialize its clinical stage inherited retinal disease drug portfolio.

# In 2019, Novartis signed an agreement with Shionogi (Japan) to commercialize new treatment, Rizmoic (Naldemedine) for Opiod-induced constipation in key European countries of Germany, UK and Netherlands, with rights of first refusal for some other European markets.

North America was the largest regional market for pharmaceutical drug delivery in 2019

The global pharmaceutical drug delivery market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the market.

The large share of the North American market can be attributed to factors such as growth in biologics in the pharmaceuticals market; the rising prevalence of chronic diseases increasing patient compliance to innovative drug delivery technologies; and the presence of a large number of prominent players in this region.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Major Leaders:

The pharmaceutical drug delivery market is highly fragmented in nature with several big and emerging players. Johnson & Johnson, Inc. (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Pfizer, Inc. (US), Sanofi (France), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), 3M (US), Antares Pharma, Inc. (US), and Becton, Dickinson and Company (BD) (US) are some of the leading players operating in the global pharmaceutical drug delivery market.

Players in this market pursue the strategies of product approvals, partnerships, agreements, collaborations, expansions, and acquisitions to develop and expand their market presence. Product approvals has been the key growth strategy adopted by players to expand their share in the market.

Protein Assays Market is Expecting Major Tech Innovations in Near Future

Target Audience for this Report:

# Protein assay manufacturers and vendors

# Distributors of protein assays

#Various research and consulting companies

# Associations related to pharmaceutical and biotechnological research

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the protein assays market, along with revenue estimates & forecasts and market share analysis.

The global protein assays application market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022.

The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research are the major factors driving the growth of this market. In this report, the global protein assays market is segmented based on type, product, technology, application, end user, and region.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

The protein assays market, by application, is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of protein assays used to diagnose cancer; immune system diseases; and liver, kidney, and bone marrow diseases.

On the basis of end user, the protein assays application market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The growth in this segment can primarily be attributed to the increasing drug development in the life science industry.

On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.

Some of the major players operating in the protein assays market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547

Some of the leading players that adopted this strategy include Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), Abcam plc. (U.S.), and PerkinElmer Inc. (U.S.).

Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations.